FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Markets

Pricing
Access
Commercial
Launch Tracking

M&A Watch

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Company

Alcon Laboratories, Inc.

Pharmaceutical intelligence for Alcon Laboratories, Inc. with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Assets: 0

Recent signals(1)

ClinicalAugust 15, 2026

Study on Intraocular Pressure During Cataract Surgery Using ACTIVE SENTRY

A study led by Centre hospitalier de l'Université de Montréal is assessing outcomes of cataract surgery using physiological intraocular pressure with the Active Sentry handpiece compared to traditional high IOP levels.

Upcoming catalysts

No catalysts indexed for this entity yet.

Regulatory activity

No signals indexed for this entity yet.

Clinical activity(1)

ClinicalAugust 15, 2026

Study on Intraocular Pressure During Cataract Surgery Using ACTIVE SENTRY

Competitive activity

No signals indexed for this entity yet.

Assets

No related entities indexed yet.

Therapeutic areas

Cataracts →

Ophthalmology →

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.